Iterum Therapeutics plc

Nasdaq:ITRM

Pharmaceutical Preparations·DUBLIN 1, L2

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	2/7/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
11/14/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
2/7/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

60 shown

Filed	Type	Description
3/3/26	Other	Other Events	→
3/2/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
2/18/26	Vote	Submission of Matters to a Vote of Security Holders	→
12/12/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
10/16/25	Other	Other Events	→
9/10/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
10/16/25	424B5	424B5	→
4/30/25	424B5	424B5	→
2/7/25	S-3	S-3	→
12/10/24	424B5	424B5	→
10/30/24	424B5	424B5	→
10/28/24	424B5	424B5	→
↓

Filing History(506 filings)

TypeDateAccessionPeriodSize

8-K

Mar 3, 2026

0001193125-26-0884948-K

Mar 3, 2026

148.7 KB

8-K

Mar 2, 2026

0001193125-26-0856468-K

Feb 24, 2026

147.8 KB

8-K

Feb 18, 2026

0001193125-26-0573938-K

Feb 18, 2026

167.2 KB

DEFA14A

Feb 13, 2026

0001193125-26-051546DEFA14A

—

36.7 KB

DEFA14A

Jan 26, 2026

0001193125-26-022666DEFA14A

—

36.6 KB

DEF 14A

Jan 2, 2026

0001193125-26-001078DEF 14A

Jan 2, 2026

3.1 MB

PRE 14A

Dec 23, 2025

0001193125-25-331139PRE 14A

Dec 23, 2025

2.7 MB

8-K

Dec 12, 2025

0001193125-25-3177288-K

Dec 11, 2025

146.8 KB

Nov 20, 2025

0001193125-25-2888484

Nov 18, 2025

4.4 KB

10-Q

Nov 14, 2025

0001193125-25-28155710-Q

Sep 30, 2025

12.6 MB

8-K

Nov 14, 2025

0001193125-25-2815318-K

Nov 14, 2025

486.8 KB

8-K

Oct 16, 2025

0001193125-25-2415568-K

Oct 16, 2025

178.4 KB

424B5

Oct 16, 2025

0001193125-25-241550424B5

—

773.5 KB

8-K

Sep 10, 2025

0000950170-25-1139868-K

Sep 10, 2025

185.7 KB

8-K

Aug 28, 2025

0000950170-25-1119748-K

Aug 25, 2025

143.5 KB

8-K

Aug 20, 2025

0000950170-25-1103708-K

Aug 20, 2025

219.9 KB

Aug 12, 2025

0000950170-25-1069084

Aug 8, 2025

4.4 KB

10-Q

Aug 5, 2025

0000950170-25-10240010-Q

Jun 30, 2025

12.3 MB

8-K

Aug 5, 2025

0000950170-25-1023948-K

Aug 5, 2025

495.0 KB

8-K

Aug 4, 2025

0000950170-25-1019718-K

Jul 29, 2025

146.3 KB

DEF 14A

Jul 29, 2025

0000950170-25-099285DEF 14A

Jul 28, 2025

6.6 MB

8-K

Jul 18, 2025

0000950170-25-0969848-K

Jul 17, 2025

148.4 KB

PRE 14A

Jul 18, 2025

0000950170-25-096760PRE 14A

Jul 18, 2025

6.6 MB

Jul 3, 2025

0000950170-25-0938724

Jul 1, 2025

5.5 KB

Jul 3, 2025

0000950170-25-0938663

Jul 1, 2025

13.0 KB

25 filings shown

Filed	Form	Description
2/19/25	EFFECT	EFFECT	→
2/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/13/24	EFFECT	EFFECT	→
8/9/24	POS AM	POS AM	→
7/19/24	EFFECT	EFFECT	→
10/17/22	EFFECT	EFFECT	→
↓

Iterum Therapeutics plc

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(506 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/13/26	DEFA14A	DEFA14A	→
1/26/26	DEFA14A	DEFA14A	→
1/2/26	DEF 14A	DEF 14A	→
12/23/25	PRE 14A	PRE 14A	→
7/29/25	DEF 14A	DEF 14A	→
7/18/25	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
11/20/25	4	4	→
8/12/25	4	4	→
7/3/25	4	4	→
7/3/25	3	3	→
3/18/25	3	3	→
1/23/25	4	4	→
↓